West Pharmaceutical Services, Inc. (WST) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

West Pharmaceutical Services, Inc. (WST) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI | MarketCI

WST

Market Closed

West Pharmaceutical Services, Inc.

NYSEHealthcare Medical - Instruments & Supplies

10.60K employees

CEO: Eric Green

Founded: 1980

$328.03

+$0.00(+NaN%)

Market Cap

23.17B

Beta

1.18

52W Range

N/A

Dividend Yield

0.27%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Gross Margin

35.9%

10.1%

CAGR: -1.5%

Profit after direct costs

Operating Margin

20.1%

3.8%

CAGR: -5.0%

Core business profitability

Net Margin

16.1%

0.2%

CAGR: -7.1%

Bottom line profitability

Revenue Growth

6.3%

YoY

CAGR: 2.1%

Top line growth rate

Revenue Flow Analysis

Visual flow showing how WST allocates revenue across expenses and profit

Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin

35.9%

$1.10B

Operating Margin

20.1%

$617.40M

Net Margin

16.1%

$493.70M

Detailed Income Statement

Complete profit and loss breakdown with margin analysis and historical comparison

Item	2021	2022	2023	2024	2025	YoY Change
Total Revenue	2.83B	2.89B	2.95B	2.89B	3.07B	6.3%
Cost of Revenue	(1.66B)	(1.75B)	(1.82B)	(1.89B)	(1.97B)	4.2%
Gross Profit	1.17B	1.14B	1.13B	1.00B	1.10B	10.1%
Operating Expenses
Research & Development	(52.80M)	(58.50M)	(68.40M)	(69.10M)	(74.30M)	7.5%
Selling, General & Administrative	(361.90M)	(316.90M)	(353.40M)	(338.50M)	(393.10M)	16.1%
Depreciation & Amortization	(122.30M)	(120.60M)	(137.30M)	(155.40M)	(124.40M)	-19.9%
Operating Income (EBIT)	758.70M	763.50M	710.90M	594.60M	617.40M	3.8%
Non-Operating Items
Interest Income	1.00M	5.10M	28.00M	19.60M	17.70M	-9.7%
Interest Expense	(8.50M)	(7.60M)	(8.80M)	(2.90M)	(600.00K)	-79.3%
Other Income/Expenses (Net)	10.30M	-62.90M	4.80M	5.60M	-2.10M	-137.5%
Income Before Tax	769.00M	700.60M	715.70M	600.20M	615.30M	2.5%
Income Tax Expense	(107.20M)	(114.70M)	(122.30M)	(107.50M)	(121.60M)	13.1%
Net Income	661.80M	585.90M	593.40M	492.70M	493.70M	0.2%
Per Share Metrics
Earnings Per Share (Basic)	$9	$8	$8	$7	$7	1.2%
Weighted Avg Shares Outstanding	74.40M	74.40M	74.30M	73.00M	72.30M	-1.0%
Weighted Avg Shares Outstanding (Diluted)	76.30M	75.80M	75.30M	73.70M	72.70M	-1.4%
EBITDA	879.70M	808.10M	844.10M	743.80M	723.60M	-2.7%

Explore WST

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

WST in the Healthcare

Large Cap

Healthcare

Browse sector stocks →

Medical - Instruments & Supplies

Browse industry stocks →